Peter C. Adamson, MD, of The Children’s Hospital of Philadelphia’s Division of Oncology, is the only pediatric oncologist to currently serve on the National Cancer Advisory Board.

The American Thyroid Association released its first guidelines for evaluating and managing thyroid nodules and thyroid cancer in children.

Margaret Foti, PhD, MD (hc), chief executive officer (CEO) of the American Association for Cancer Research (AACR), has been recognized with the Children’s Champion Award for her outstanding pediatric cancer advocacy efforts.

Delving into the world of the extremely small, CHOP researchers are exploring how nanoparticles can precisely deliver anticancer drugs to attack neuroblastoma.

At the invitation of the White House, CHOP sent two guests to President Obama’s announcement of the Precision Medicine Initiative: Dr. Altschuler and Emily Whitehead.

An innovative cell therapy against a highly aggressive form of acute lymphoblastic leukemia (ALL) continues to show highly promising results in children treated in a pilot study.

CHOP and Penn Medicine experts are refining their diagnostic tools to predict which patients are more likely to respond to drugs called ALK inhibitors that target such mutations, setting the stage for a phase 3 clinical trial.

CHOP announces the selection of Stephen P. Hunger, MD, a nationally prominent specialist in children’s cancer, as its new chief of the Division of Oncology and the director of the Center for Childhood Cancer Research.

Read a case study about a previously healthy 12-year-old boy presented to CHOP Urgent Care with fever and nonproductive cough.

Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) went into remission after receiving an investigational therapy, CTL019.